Prevalence of Unrecognized Dyslipidaemia in Dubai and Northern Emirates: A Cross-Sectional Hospital Based Study

被引:0
作者
Vela, Barbara Karin [1 ]
Alhessi, Alaaeldin Y. [2 ]
Popovic, Marko [3 ]
Al-Shaqra, Maryam A. [4 ]
机构
[1] Dubai London Clin, Dubai, U Arab Emirates
[2] Emirates Hosp, Dubai, U Arab Emirates
[3] Vipnet, Zagreb, Croatia
[4] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates
关键词
dyslipidaemia; LDL cholesterol; HDL cholesterol; prevalence; United Arab Emirates;
D O I
暂无
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
The aim of this study is to determine the prevalence of unrecognized dyslipidaemia and a specific correlation between lipid values and age, gender or ethnic origin in the study population. This retrospective cross-sectional study included 311 subjects who had their lipid profiles checked for the first time in a private hospital in Dubai in a six month - period. The analysis shows an increased prevalence of Low Density Lipoprotein (LDL) hypercholesterolemia with relatively higher Low Density Lipoprotein Cholesterol (LDL-c) values in male subjects (p<0.016) as well as with the Middle East ethnic origin group (p<0.025), while desirable High Density Lipoprotein (HDL-c) was found among female subjects (p=0). The discordance between the percentages of elevated LDL-c and Total cholesterol (T-c) signifies the role of the LDL-c/non-HDL-c as the main surrogate for dyslipidaemia as a risk for atherosclerosis, and as a primary target of therapy.
引用
收藏
页码:1087 / 1092
页数:6
相关论文
共 21 条
  • [11] Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world
    Levi, F
    Lucchini, F
    Negri, E
    La Vecchia, C
    [J]. HEART, 2002, 88 (02) : 119 - 124
  • [12] INFLUENCE OF TOTAL CHOLESTEROL, HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, AND TRIGLYCERIDES ON RISK OF CEREBROVASCULAR-DISEASE - THE COPENHAGEN CITY HEART-STUDY
    LINDENSTROM, E
    BOYSEN, G
    NYBOE, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6946): : 11 - 15
  • [13] Recent trends in acute coronary heart disease - Mortality, morbidity, medical care, and risk factors
    McGovern, PG
    Pankow, JS
    Shahar, E
    Doliszny, KM
    Folsom, AR
    Blackburn, H
    Luepker, RV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (14) : 884 - 890
  • [14] Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
    Mokdad, AH
    Ford, ES
    Bowman, BA
    Dietz, WH
    Vinicor, F
    Bales, VS
    Marks, JS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (01): : 76 - 79
  • [15] Rethinking primary prevention of atherosclerosis-related diseases
    Napoli, Claudio
    Lerman, Lilach O.
    de Nigris, Filomena
    Gossi, Mario
    Balestrieri, Maria Luisa
    Lerman, Amir
    [J]. CIRCULATION, 2006, 114 (23) : 2517 - 2527
  • [16] PEDERSEN TR, 1994, LANCET, V344, P1383
  • [17] Pongchaiyakul Choowong, 2005, Journal of the Medical Association of Thailand, V88, P1092
  • [18] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
    Sever, PS
    Dahlöf, B
    Poulter, NR
    Wedel, H
    Beevers, G
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    [J]. LANCET, 2003, 361 (9364) : 1149 - 1158
  • [19] Prevalence, awareness and treatment of hypercholesterolaemia in 32 populations: results from the WHO MONICA Project
    Tolonen, H
    Keil, U
    Ferrario, M
    Evans, A
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (01) : 181 - 192
  • [20] WALLACH J, 2000, INTERPRETATION LAB T